TNF and rheumatoid arthritis: Interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) play a critical role in the induction and progression of rheumatoid arthritis (RA), and the efficacy of therapies targeting these two inflammatory cytokines confirms their prominent role in the disease [1].